Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Third party request |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Antibody Screening |
| Species: | Human |
| Stage: | Assays Completed |
| Study Start Date: | 2016-01-18 |
| Study Made Public: | 2016-10-20 |
Title
ART testing by MLV Neutralization Assay
Description
CAVD 540 (TP029) is a monoclonal antibody study to determine if an HIV-1 incidence assay can be developed as a prediction tool for an HIV-1 incidence algorithm.
Sign in to see full information about this study and to download study data.
Products
No Products used in studyIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.